Takako Asano Selected Research

Kidney Neoplasms (Kidney Cancer)

1/2020	Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells.
10/2018	Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress.
10/2018	Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells.
8/2018	Nelfinavir Induces Endoplasmic Reticulum Stress and Sensitizes Renal Cancer Cells to TRAIL.
6/2018	Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells.
8/2017	Docosahexaenoic acid inhibits the phosphorylation of STAT3 and the growth and invasion of renal cancer cells.
1/2016	Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer Cells.
11/2015	Bortezomib and belinostat inhibit renal cancer growth synergistically by causing ubiquitinated protein accumulation and endoplasmic reticulum stress.
11/2014	Ritonavir acts synergistically with panobinostat to enhance histone acetylation and inhibit renal cancer growth.
8/2014	Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takako Asano Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 08/2002
27	Kidney Neoplasms (Kidney Cancer) 01/2020 - 08/2002
15	Renal Cell Carcinoma (Grawitz Tumor) 04/2017 - 08/2002
12	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 02/2004
7	Neoplasm Metastasis (Metastasis) 01/2012 - 08/2002
5	Lymphatic Metastasis 07/2017 - 08/2004
5	Prostatic Neoplasms (Prostate Cancer) 12/2012 - 03/2002
4	Carcinogenesis 04/2020 - 10/2006
4	Carcinoma (Carcinomatosis) 04/2020 - 05/2014
3	Wounds and Injuries (Trauma) 10/2017 - 08/2008
2	Proteinuria 11/2013 - 04/2010
2	Fibrosis (Cirrhosis) 04/2010 - 12/2004
2	Sclerosis 04/2010 - 05/2009
2	Ureteral Obstruction 04/2010 - 12/2004
2	Obesity 10/2006 - 10/2006
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 05/2021
1	Margins of Excision 04/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Ascites 01/2020
1	Urologic Neoplasms (Urological Cancer) 11/2019

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 06/2021 - 06/2005
10	Ritonavir (Norvir)FDA Link 12/2021 - 09/2010
9	Histone Deacetylase InhibitorsIBA 09/2021 - 09/2010
7	Proteasome InhibitorsIBA 12/2021 - 04/2012
6	Histone Deacetylases (Histone Deacetylase)IBA 12/2021 - 09/2010
6	Histones (Histone)IBA 09/2021 - 04/2012
5	Vorinostat FDA Link 01/2020 - 09/2010
5	Protease Inhibitors (Protease Inhibitor)IBA 11/2019 - 09/2010
5	Bortezomib (Velcade)FDA Link 11/2015 - 04/2012
4	PanobinostatIBA 04/2019 - 08/2014
4	HIV Protease InhibitorsIBA 06/2018 - 04/2012
4	matrigelIBA 10/2017 - 10/2006
4	ParaffinIBA 01/2015 - 08/2004
4	Small Interfering RNA (siRNA)IBA 07/2012 - 03/2007
4	Topotecan (Hycamtin)FDA LinkGeneric 01/2011 - 03/2007
3	Phosphotransferases (Kinase)IBA 01/2022 - 03/2013
3	CytokinesIBA 01/2020 - 10/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 03/2003
3	LigandsIBA 11/2019 - 03/2003
3	Annexin A5IBA 10/2018 - 04/2012
3	Nelfinavir (Viracept)FDA Link 10/2018 - 03/2018
3	Ubiquitinated ProteinsIBA 06/2017 - 12/2012
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 05/2014 - 08/2008
3	Transforming Growth Factor beta (TGF-beta)IBA 04/2010 - 05/2003
3	Gefitinib (Iressa)FDA Link 07/2009 - 01/2004
3	SurvivinIBA 05/2009 - 03/2007
2	Gemcitabine FDA Link 01/2022 - 01/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2021 - 04/2012
2	ixazomibIBA 06/2021 - 06/2017
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2021 - 03/2018
2	p21-Activated KinasesIBA 04/2020 - 01/2015
2	GuanosineIBA 04/2020 - 10/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 12/2004
2	Fluvastatin FDA Link 01/2020 - 12/2004
2	AMP-Activated Protein KinasesIBA 01/2020 - 04/2019
2	Antineoplastic Agents (Antineoplastics)IBA 04/2019 - 10/2018
2	Docosahexaenoic AcidsIBA 08/2017 - 07/2016
2	belinostatIBA 01/2016 - 11/2015
2	Formaldehyde (Formol)FDA Link 01/2015 - 01/2011
2	Erythropoietin FDA Link 11/2014 - 06/2012
2	Topoisomerase I InhibitorsIBA 01/2011 - 05/2009
2	Peptides (Polypeptides)IBA 04/2010 - 02/2004
2	AntibodiesIBA 07/2008 - 02/2004
2	LeptinIBA 10/2006 - 10/2006
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2006 - 01/2004
2	Leptin ReceptorsIBA 10/2006 - 10/2006
2	Oxidoreductases (Dehydrogenase)IBA 12/2004 - 12/2004
2	ErbB Receptors (EGF Receptor)IBA 02/2004 - 01/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2004 - 03/2003
2	Protein Kinase CIBA 01/2004 - 03/2002
1	ceralasertibIBA 01/2022
1	Cytochrome P450 Family 3IBA 12/2021
1	romidepsin (FK228)FDA Link 09/2021
1	Simvastatin (Zocor)FDA LinkGeneric 09/2021
1	ONX 0912IBA 06/2021
1	UbiquitinIBA 06/2021
1	TAK-243IBA 06/2021
1	Cisplatin (Platino)FDA LinkGeneric 06/2021
1	Annexin A2 (Annexin II)IBA 05/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021
1	MK-8776IBA 01/2021
1	Checkpoint Kinase 1IBA 01/2021
1	rac1 GTP-Binding ProteinIBA 04/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 11/2019
1	Lopinavir FDA Link 11/2019
1	TOR Serine-Threonine KinasesIBA 04/2019
1	Metformin (Glucophage)FDA LinkGeneric 04/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2019
1	IsoflavonesIBA 10/2018
1	phenoxodiolIBA 10/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018
1	Death Domain ReceptorsIBA 08/2018

Therapy/Procedure

11	Therapeutics 01/2022 - 08/2002
2	Nephrectomy 11/2014 - 05/2003
2	Prostatectomy (Retropubic Prostatectomy) 01/2012 - 07/2008
1	Transurethral Resection of Bladder 05/2021
1	Intravesical Administration 05/2021
1	Drug Therapy (Chemotherapy) 05/2021